logo

PSNC News

  • MHRA – Class 4 Medicines Defect Information: Venlafaxine XL 300 mg prolonged-release tablets (Macarthys Laboratories t/a Martindale Pharma)

    Class 4 Medicines Defect Information: Venlafaxine XL 300 mg prolonged-release tablets (Macarthys Laboratories t/a Martindale Pharma) Drug alert number: EL (22)A/47 Date issued: 16 November 2022 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Venlafaxine XL 300 mg prolonged-release tablets, PL 01883/0363 Batch Number Expiry

    Read more

  • Two weeks left to complete mandatory workforce survey

    Community pharmacy contractors are reminded of the mandatory requirement to complete the 2022 Community Pharmacy Workforce Survey, managed by Health Education England (HEE), by 30th November 2022. Completion of the survey is a mandatory requirement for all contractors. The NHS Business Services Authority (NHSBSA) sent an email to contractors on 6th October 2022 containing a link to the

    Read more

  • Reminder: Packaged dose endorsement on prescriptions for methadone oral liquid

    When dispensing FP10MDA or FP10 prescriptions for methadone oral liquid, pharmacy contractors can claim packaged dose fees of £0.55 for each individual dose supplied in advance in daily dose containers. The number of packaged dose (‘PD’) fees to claim for is calculated as the total number of separately packaged doses given minus the number of

    Read more

  • PSNC launches new political influencing campaign

    PSNC is this week launching a new influencing campaign to build wider political support for community pharmacies and ensure that MPs and Peers across Parliament understand the risks to pharmacy services that the current pressures on the sector are causing. In a Parliamentary event to be held tomorrow (Tuesday 15th November) MPs and Peers will

    Read more

  • Mandatory national audit announced

    PSNC and NHS England have agreed that the 2022/23 national clinical audit will focus on valproate, with the aim of reducing the potential harm caused by taking valproate during pregnancy. The audit must be completed by all community pharmacy contractors as this is part of their NHS contractual requirements. Read the audit paperwork Contractors will be required to

    Read more

  • Survey suggests public lacks confidence to treat some common conditions

    More than half of people (52%) do not feel confident in treating backache and over a quarter of people (27%) would go to their GP or A&E for conditions that they could treat themselves at home, a survey on self-care attitudes has revealed. PAGB, the consumer healthcare association, surveyed over 2,000 adults across the UK about

    Read more

  • Share your views on pharmacy’s role in promotion of continence

    Pharmacy teams are invited to participate in an interview and focus group discussions to explore current practice in community pharmacy regarding the management of individuals who present with bladder and/or bowel incontinence. The opportunity follows a survey conducted earlier this year to gather opinions. Approximately 1 in 5 people experience bladder or bowel leakage and

    Read more

  • PSNC publishes TAPR Progress Report

    PSNC is continuing to make progress on addressing the Review Steering Group (RSG) proposals and has today published a series of resources to update contractors and LPCs on this work. PSNC is taking forward the RSG proposals directed at the Committee through its Transforming Pharmacy Representation (TAPR) work programme. Alongside an update on the TAPR

    Read more

  • PSNC to host Parliamentary drop-in event on Hypertension Service

    On Tuesday 15th November, PSNC will be hosting a Parliamentary drop-in event for MPs. The event will last for roughly two hours, during which MPs will have the opportunity to drop-in and have their blood pressure measured by a fully qualified pharmacist. This event will be a great opportunity to talk to MPs from across

    Read more

  • Pharmacy Vision: First chance to share views

    PSNC has today launched an open consultation to hear from contractors, LPCs and others in the sector about their views on the future of community pharmacy. The consultation – which takes the form of an online survey – is the first opportunity within PSNC’s vision project for individuals and organisations to share their thoughts with Nuffield

    Read more
© 2025 Middlesex Pharmaceutical Group